Medical therapies for IBD include oral or rectal 5-ASA drugs, immunomodulators, biologicals, and other newer agents with different targets and mechanisms of action For patients with mild to moderate UC, 5-ASA drugs are effective for achieving remission and maintenance Rarely, patients have serious adverse events with 5-ASA drugs (eg, interstitial nephritis, pericarditis, pneumonitis, hepatitis, or pancreatitis) Antibiotics Controlled trials of various antibiotics have not demonstrated efficacy in treating UC
Agbalalah, T., Robert, F
Photoprotection: against UVB, UVA, UVA1, + blue light
Injection-site and general considerations Beyond sterility, subcutaneous injection carries the ordinary risks of any injection: local irritation, bruising, nodules, and the possibility of allergic or hypersensitivity reactions